In this episode Jonathan Rosenfeld chats with Martin D. Gould (https://rblaw.net/attorneys/martin-d-gould/) an Attorney at Romanucci & Blandin, LLC (https://rblaw.net/). (https://lanzonemorgan.com/) Here, they discuss: Zantac Cancer Lawsuit FAQ: 4 Most Asked Questions (https://www.rosenfeldinjurylawyers.com/zantac-cancer-lawsuits.html)   Read the Transcript Download the PDF Jonathan Rosenfeld: Hello, and good afternoon. I am Jonathan Rosenfeld, and today I am joined by Marty Gould. Marty is currently working on many lawsuits involving Zantac and the development of cancer. Marty, first off, thank you for joining me today, I appreciate it. Marty Gould: Thanks for having me on, Jon. Jonathan Rosenfeld: Now, Marty, this is a really quickly emerging area of mass tort litigation that we're seeing. A lot of people have been taking Zantac and the generic version of Zantac over the past 10, 20 years. And today we are learning that some of these people are developing various types of cancers after taking these drugs, both prescription and over the counter. Today I want to run through with you some of the most frequently asked questions by people related to this litigation. I want to run through the four most common questions asked by people who have a potential Zantac case. These are based on the data that we're seeing today from Google search, frankly. I wanted to go through with you quickly, so we can get this information to people in a concise way. First off, has Zantac been withdrawn from the market? Marty Gould: Yes, it has. Jon, in September, 2019, the US Food and Drug Administration reported that there was a link between one of the ingredients of Zantac and NDMA in cancer, and they issued a public warning. And then in April, 2020, the FDA announced that all Zantac brand heartburn drugs, prescription and over the counter, should be immediately pulled from the market because of potential NDMA contamination. And subsequently, retailers across the country, Walmart, Walgreens, CVS, suspended the sale of the over-the-counter Zantac and ranitidine products. Jonathan Rosenfeld: Second question for you, what type of cancer is related to Zantac use? What types of cancers are you seeing today in claims and lawsuits that you are filing against the different manufacturers of these drugs? Marty Gould: We represent hundreds and hundreds of individuals that have cancer because of Zantac use, or in tragic situations, the families of people deceased because of that cancer. From our experiences and from the research, the cancers most commonly linked to Zantac use or ranitidine use are bladder cancer, colon cancer, prostate cancer, kidney cancer, liver cancer, stomach cancer, and breast cancer. There's also some potential cancers that have a weaker link to the use of Zantac that we're still looking at, and those include pancreatic, ovarian, and melanoma. Jonathan Rosenfeld: One of the questions that we're seeing over and over again by people, is there a settlement related to Zantac lawsuits at this time, as of today's date, we are today April, 2021? Is there a Zantac lawsuit settlement? Marty Gould: There is not a Zantac lawsuit settlement yet, at least not on a wide scale. The cases are all being consolidated, or most of them are, in a multi-district litigation in federal court. There hasn't been any bellwether cases yet, but we're very optimistic that there is going to be a settlement and a resolution for our clients and for many of the other victims and survivors out there. Jonathan Rosenfeld: Along these lines, a lot of people are also looking into what the value of these cases are.